Plain-English translation of NCT07555717 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new vascular graft called STARgraft (10401) that creates an access point in your arm for hemodialysis treatment. The graft is a small tube that connects an artery and vein, allowing dialysis needles to be inserted more easily. Researchers want to see if this new graft works better and lasts longer than standard grafts currently used.
People with end-stage kidney disease need dialysis to filter waste from their blood, and they need a reliable access point in their arm where needles can be placed repeatedly. Standard grafts sometimes fail or develop problems, so doctors are testing whether the new treatment can be more durable and reduce complications.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo surgery to have the STARgraft placed in your upper arm as your dialysis access. You will then be monitored for 6 months with follow-up visits to check how well the graft is working, and researchers may continue collecting data for up to 3 years. During your follow-up visits, you'll have ultrasounds or other imaging tests to ensure the graft remains healthy and functioning.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Paraguay